COMPANY PROFILE

AdjuCor

Adjucor develops a cardiac-assist device for advanced heart failure patients. The device maintains the heart's function while avoiding blood contact

Munich, GermanyFounded 2012Health Tech & Medtech

Valuation $100–500M Latest valuation · 2021

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About AdjuCor

Developer of a heart assist device designed to assist patients with advanced heart problems. The company utilizes technology that covers the diseased heart and supports it in its function and develops a device that assists the heart while completely avoiding the complication-laden aspect of blood contact, enabling healthcare professionals to enhance the care of patients with heart failure and improve their quality of life.s Keywords: Healthcare Devices, Services, Supplies, Healthcare Tech, Heart Assisting Device, Heart Assisting Technology, Heart Failure, Heart Failure Treatment, Implantable Device, Med Tech, Medical Device.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: Munich, Germany
Employees: 26
Open positions: None listed
Dealroom signal: 63.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Cardiology and cardiovascular, Sustainable Development Goals, Electrocardiogram, EIC, Tech for Hospitals and Clinics, Hard Tech, Horizon Europe
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning AdjuCor.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANTOther financing	Mar 2022	$2.5M	—	European Innovation Council	—
SERIES BOther financing	Jun 2021	$32M	$128M	Maurizio Group · MitrAssist	—

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

AdjuCor website traffic

Latest recorded traffic for AdjuCor is 410 monthly website visits, up 13.9% over the last three months. AdjuCor's team declined 10.3% over the past year.

Latest monthly visits410 3-month web change+13.9% 1-year team growth-10.3%

Monthly website visitsMar 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
FEFeopsCutting-edge technology that creates digital twins from cardiac scans	Ghent, Belgium	Acquired	35	$12M	$26M
PMPowerful MedicalA deep-tech company tackling the most challenging problems of modern medicine using artificial intelligence and machine learning	Bratislava, Slovakia	Operational
HYHylomorphHylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implantable medical devices and tissues	Zurich, Switzerland	Operational
TMTriSol MedicalFocuses on developing a transcatheter tricuspid valve replacement	Yokneam Ilit, Israel	Operational
NENeurescueDeveloping cardiovascular devices to help emergency patients	Copenhagen, Denmark	Operational
VBVital BeatsVital Beats software platform delivers AI-powered diagnostics and remote follow-up for patients with cardiac devices and wearables	Copenhagen, Denmark	Operational
NONovostiaNovostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children	Neuchâtel, Switzerland	Operational
LILigenceAI-powered echo analysis for faster, better care	Vilnius, Lithuania	Operational